Belite Bio
BLTE
22 hedge funds and large institutions have $17.8M invested in Belite Bio in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
383% more capital invested
Capital invested by funds: $3.69M → $17.8M (+$14.1M)
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
47% more funds holding
Funds holding: 15 → 22 (+7)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.66% more ownership
Funds ownership: 0.26% → 0.91% (+0.66%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$11.1M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$796K |
| 3 |
Morgan Stanley
New York
|
+$656K |
| 4 |
JP Morgan Chase
New York
|
+$546K |
| 5 |
Goldman Sachs
New York
|
+$417K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$225K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$173K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$94.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$82.3K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$47.5K |
BLTE Hedge Fund Activity: Q4 2024 in Review
22 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q4 2024, worth a combined $17.8M — up 383% from $3.69M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BLTE positions and 2 closed out — a net gain of 7 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $11.1M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $225K sold.
- 22 institutional investors held Belite Bio (BLTE) as of Q4 2024, up from 15 in Q3 2024.
- Funds reported $17.8M of Belite Bio stock for Q4 2024, up 383% quarter-over-quarter.
- 9 funds opened new Belite Bio positions in Q4 2024 and 2 closed out, a net change of +7 holders.
- The largest Belite Bio buyer in Q4 2024 was Armistice Capital, an estimated $11.1M added.
- The largest Belite Bio seller in Q4 2024 was Point72 Asset Management, an estimated $225K sold.
Based on aggregated 13F filings for Q4 2024.